Back to User profile » Dr Yufeng Wu
Papers published by Dr Yufeng Wu:
Anlotinib Combined with Cranial Radiotherapy for Non-Small Cell Lung Cancer Patients with Brain Metastasis: A Retrospectively, Control Study
He Z, Liu J, Ma Y, Jiang H, Cui Z, Wang G, Wu Y, Liu J, Cai X, Qian J, Huang J, Zhang H, Li H
Cancer Management and Research 2021, 13:6101-6111
Published Date: 4 August 2021
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Perioperative chemotherapy with pemetrexed and cisplatin for pulmonary large-cell neuroendocrine carcinoma: a case report and literature review
Tang H, Wang HY, Xi SY, He CY, Chang YX, Wang QM, Wu YF
OncoTargets and Therapy 2018, 11:2557-2563
Published Date: 7 May 2018
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
PET-CT evaluation of the curative effect of crizotinib on malignant myofibroblastoma with rare mutation of ALK R401: a case report and literature review
Yang L, Wu Y, Tang H, Zhao J, Zhao D, Yang S, Wang Q
OncoTargets and Therapy 2018, 11:1921-1927
Published Date: 5 April 2018
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Predictive significance of HMGCS2 for prognosis in resected Chinese esophageal squamous cell carcinoma patients
Tang H, Wu Y, Qin Y, Wang H, Jia Y, Yang S, Luo S, Wang Q
OncoTargets and Therapy 2017, 10:2553-2560
Published Date: 15 May 2017
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Reduction of AZGP1 predicts poor prognosis in esophageal squamous cell carcinoma patients in Northern China
Tang H, Wu Y, Qin Y, Wang H, Wang L, Guan X, Luo S, Wang Q
OncoTargets and Therapy 2017, 10:85-94
Published Date: 20 December 2016